CORONAVIRUS INFO PROVIDED BY DR. JIM HARRIS – 4/8/2022
B2.A is not crowding our hospitals, but it has been identified in all states. I will be away from my computer for several days.
FROM NYT today:
”Cases have doubled in Washington and have risen about 60 percent in New York City since the last week of March, according to New York Times databases….The virus raced through parts of Washington, as well, where several politicians tested positive this week after attending parties and events…”
FROM HOPKINS SELECTIONS:
1. China Kintor’s COVID Drug Candidate Cuts Hospital, Death Risk in Trial (Reuters) China’s Kintor Pharmaceutical (9939.HK) said on Wednesday its potential COVID-19 treatment proxalutamide effectively reduced the risk of hospitalization and death in a clinical trial involving outpatients with mild to moderate symptoms. The results came from a multi-national clinical trial with over 700 subjects across the world, mostly from the United States, recruited during April-December, 2021, who were given either proxalutamide or a placebo, the company said in a filing.
MORE ABOUT: Proxalutamide
An inhibitor of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2) proteins, proxalutamide hinders the SARS-CoV-2 virus’ entry into host cells….
Proxalutamide is an antagonist at the androgen receptor which leads to inhibition of androgen-induced receptor activation and results in formation of inactive complexes that are not able to translocate to the nucleus. It also induces androgen receptor downregulation, furthering adrogen-induced receptor activation. This drug is being investigated for its potential antineoplastic activity and is being investigated specifically against prostate cancer and COVID-19.
AND LASTLY: I’ve been saving this one for a long weekend:
GIVE US YOUR FEEDBACK. CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.
P.O. Box 721